Sign in
4

Changes in Ownership

Arcadia Biosciences, Inc. Filed Acc 0001209191-19-061814

Chief Commercial Officer bought 900 shares at $5.95 ($5,355)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Reiter Sarah Chief Commercial Officer 2019-12-23 Purchase +900 $5.95 $5,355 3,100 D
Open-market purchases · 900 sh · avg $5.95 · $5,355
Loading xslF345X03/doc4.xml…